FINWIRES · TerminalLIVE
FINWIRES

$KLRS

2 stories mentioning KLRSUpdated 32d ago

Every FINWIRES story that references KLRS, newest first.

Research

Wedbush Initiates Kalaris Therapeutics at Outperform With $17 Price Target

Kalaris Therapeutics (KLRS) has an average rating of buy and mean price target of $19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$KLRS
Research

Morgan Stanley Initiates Kalaris Therapeutics at Overweight

Kalaris Therapeutics (KLRS) has an average rating of buy and mean price target of $19.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$KLRS